Varies. Bone loss features can vary. People may be asymptomatic to painful if associated with bone fractures. Bone mineral density (bmd) testing looks at bone quantitative amount. It does not determine bone quality. The quantity and quality of bone determine strength. Bone loss may be prevented/treated by bisphosphonates, denosumab, impact exercise, calcium, vitamin d.
Color, exudates. Feature of bone loss are: radiographic evidence, tissue color is more reddish and bleeding upon probing. Tissue texture is more glossy with a roll, rounded gum margin. Upon palpation, exudates may occur. Pain may also occur with palpation, though in many case there is no pain involved especially in a chronic condition.